OLED vs REGN
Universal Display (OLED) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Universal Display (OLED) is a electronic components company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported OLED revenue for 2024-12-31 was $647.7M. Net income was $222.1M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. OLED currently screens at market cap $7.49B and trailing P/E 32.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
OLED currently screens at market cap $7.49B and trailing P/E 32.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the OLED and REGN stock pages for the full models.
Not investment advice.